CLDN12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.259830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.030300E-02
Normal-vs-Stage2
1.220050E-01
Normal-vs-Stage3
4.329600E-01
Normal-vs-Stage4
1.048180E-01
Stage1-vs-Stage2
7.732200E-01
Stage1-vs-Stage3
4.424200E-01
Stage1-vs-Stage4
3.026600E-01
Stage2-vs-Stage3
3.880600E-01
Stage2-vs-Stage4
4.434400E-01
Stage3-vs-Stage4
2.516000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.424410E-01
Normal-vs-AfricanAmerican
9.479900E-02
Normal-vs-Asian
1.308210E-01
Caucasian-vs-AfricanAmerican
5.273600E-01
Caucasian-vs-Asian
8.074200E-01
AfricanAmerican-vs-Asian
4.312200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.293200E-01
Normal-vs-Female
1.146400E-01
Male-vs-Female
9.919900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.623200E-01
Normal-vs-Age(41-60Yrs)
4.416300E-02
Normal-vs-Age(61-80Yrs)
1.996380E-01
Normal-vs-Age(81-100Yrs)
1.146840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.043400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.629200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.378400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.482400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.063010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.036370E-01
Normal-vs-Daily Drinker
2.076000E-01
Normal-vs-Weekly Drinker
3.083200E-01
Normal-vs-Occasional Drinker
1.017230E-01
Normal-vs-Social Drinker
3.034600E-01
Non Drinker-vs-Daily Drinker
3.236600E-01
Non Drinker-vs-Weekly Drinker
3.683600E-01
Non Drinker-vs-Occasional Drinker
1.799820E-01
Non Drinker-vs-Social Drinker
8.366000E-01
Daily Drinker-vs-Weekly Drinker
9.288000E-01
Daily Drinker-vs-Occasional Drinker
5.160400E-02
Daily Drinker-vs-Social Drinker
4.524200E-01
Weekly Drinker-vs-Occasional Drinker
9.891700E-02
Weekly Drinker-vs-Social Drinker
4.598800E-01
Occasional Drinker-vs-Social Drinker
4.916400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.413010E-01
Normal-vs-Grade 2
3.738200E-02
Normal-vs-Grade 3
8.800500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.764200E-01
Grade 1-vs-Grade 3
3.942000E-01
Grade 1-vs-Grade 4
1.413010E-01
Grade 2-vs-Grade 3
3.901000E-01
Grade 2-vs-Grade 4
3.738200E-02
Grade 3-vs-Grade 4
8.800500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.818400E-01
Normal-vs-NonDiabetic
1.091240E-01
Diabetic-vs-NonDiabetic
5.492000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.538190E-02
Normal-vs-NoPancreatitis
1.595810E-01
Pancreatitis-vs-NoPancreatitis
7.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.011620E-01
Normal-vs-N1
1.414210E-01
N0-vs-N1
9.495000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.692300E-02
Normal-vs-TP53-NonMutant
2.184200E-01
TP53-Mutant-vs-TP53-NonMutant
3.764600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
